Bronchiectasis trials in Argentina
4 of 4 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleThe AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
- Where
- Alberdi Sur, Bahía Blanca, CABA, Capital Federal, Ciudad Autonoma Buenos Aires, Mar del Plata, Quilmes, Rosario, Santa Fe
- Age
- 12 years and over
- People
- 1,755 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06872892 · EU 2024-518589-29-00 - Phase 3Not yet taking people in ArgentinaA Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)
- Where
- Alberdi Sur, Buenos Aires, CABA, Capital Federal, Ciudad Autonoma Buenos Aires, Mar del Plata, Quilmes, Rosario, Santa Fe
- Age
- 12 years and over
- People
- 1,500 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07915219 · EU 2026-527086-30-00 - Phase 2Taking peopleA Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization
- Where
- Ciudad de Buenos Aires, Florida, Rosario, San Miguel de Tucumán
- Age
- 12 years and over
- People
- 435 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07088926 - Phase 2Taking peopleA Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis
- Where
- Buenos Aires, CABA, Rosario Provincia de Santa FE, San Miguel de Tucumán, Santa Fe
- Age
- 18 years to 85 years
- People
- 363 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07201051 · EU 2025-522892-27-00